ALEX JEFFERSON: Open Payments
NPI 1588950919 · KENNETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 17 payments from 9 companies in 2025. Trend: 2023 $345 · 2024 $359 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Lundbeck LLC | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| ABBVIE INC. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: INGREZZA, UZEDY, ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, VRAYLAR, FANAPT, REXULTI.
Industry payments across MO — which companies pay providers there.
